Pharmaceuticals

Non-Steroidal Anti-inflammatory Drugs Market 2025–2029: Tracking 6.5% CAGR Toward $28.15 Billion in Revenue

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the non-steroidal anti-inflammatory drugs market from 2025–2034 with trusted insights from The Business Research Company

How Will The Non-Steroidal Anti-inflammatory Drugs Market Size Evolve Between Now And 2029?

The non-steroidal anti-inflammatory drugs market has experienced substantial growth in recent years. It is projected to expand from $20.68 billion in 2024 to $21.89 billion in 2025, at a compound annual growth rate (CAGR) of 5.8%. The historical growth in this market can be attributed to factors such as chronic inflammatory diseases, postoperative pain management, sports injuries, the convenience of over-the-counter availability, an aging population, and increased consumer awareness.

The non-steroidal anti-inflammatory drugs market size is projected to experience significant growth in the upcoming years. It is anticipated to expand to $28.15 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.5%. The projected increase in the forecast period is attributed to factors like emerging pain management therapies, regulatory changes, increased telehealth utilization, global wellness trends, biosimilar competition, evolving patient preferences, and precision medicine approaches. Major trends anticipated during this period include the dominance of the over-the-counter (OTC) market, a rising preference for cox-2 inhibitors, generics and market competition dynamics, and the integration of digital health technologies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Which Key Drivers Are Powering Growth In The Non-Steroidal Anti-inflammatory Drugs Market?

An increasing occurrence of chronic pain is anticipated to drive the expansion of the non-steroidal anti-inflammatory drugs market in the future. Chronic pain is defined as discomfort lasting longer than six months. Non-steroidal anti-inflammatory drugs serve the purpose of healing injuries and managing chronic pain. For example, a report from April 2022 by the CDC (Centers for Disease Control and Prevention), a US-based government body, indicated that arthritis, which impacts millions in the US, was a common cause of chronic pain. Roughly one in four adults out of 15 million people suffering from arthritis experience severe joint pain linked to the condition. Consequently, the rising prevalence of chronic pain is fueling the expansion of the non-steroidal anti-inflammatory drugs market.

How Is The Global Non-Steroidal Anti-inflammatory Drugs Market Structured By Key Segments?

The non-steroidal anti-inflammatory drugs market covered in this report is segmented –

1) By Route Of Administration: Oral, Topical, Other Route Of Administration

2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Oral: Tablets, Capsules, Liquids Or Solutions

2) By Topical: Gels, Creams, Patches

3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

What Future-Focused Trends Are Anticipated In The Non-Steroidal Anti-inflammatory Drugs Market?

Product innovation represents a crucial trend within the non-steroidal anti-inflammatory drugs market. Major companies operating in the non-steroidal anti-inflammatory drugs market are focusing on creating advanced technology solutions. For example, in March 2024, Endo International plc, a pharmaceutical company from Ireland, launched ibuprofen-famotidine 800 mg/26.6 mg tablets. These ibuprofen-famotidine 800 mg/26.6 mg tablets bring together the pain-relieving and anti-inflammatory properties of ibuprofen with the gastroprotective effects of famotidine. This new formulation aims to relieve pain while minimizing the potential for gastrointestinal side effects often linked with the extended use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen.

Which Companies Hold A Competitive Edge In The Non-Steroidal Anti-inflammatory Drugs Market?

Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Which Region Is Expected To Lead The Non-Steroidal Anti-inflammatory Drugs Market In The Next Few Years?

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp

Browse Through More Reports Similar to the Global Non-Steroidal Anti-inflammatory Drugs Market 2025, By The Business Research Company

Corticosteroid Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Antiemetics And Antinauseants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795